Investigators analyzed global, national, and regional trends in acute myeloid leukemia (AML), which predominantly affects individuals aged 60 to 89 years.
Although incidence and mortality rates, disability-adjusted life-years (DALYs), and estimated annual percentage change (EAPC) increased steadily over a 30-year period, the growing burden of acute myeloid leukemia (AML) was often higher in developed countries compared with developing regions, according to a report published in Frontiers of Public Health.
Globally, approximately 80% of new cases of AML occur in individuals aged 60 and older, the authors wrote. Compared with younger patients, older patients often face more complications and challenges in treatment, significantly affecting their prognosis and reducing their life expectancy, they said. AML has the highest mortality rate among the different types of leukemia.
The researchers explained that survival rates among younger patients have shown significant improvement over the years, while survival rates for older patients have seen only marginal progress.
“We aimed to provide a comprehensive analysis of the global burden of AML in older patients, contributing to the formulation of appropriate preventative and therapeutic measures against this disease,” they said.
To conduct this study, the investigators began by examining a wide range of information from 204 countries, 21 geographic regions, and 5 sociodemographic index (SDI) regions using the Global Burden of Disease database. The data included global, regional, and national incidence rates; incidence counts; mortality rates; mortality counts; DALYs rates and counts; and changes in case counts.
The investigators highlighted the annual number of incident cases, death cases, and DALYs cases for 1990 through 2019 and the change between them.
To ensure a comprehensive analysis, the researchers divided the global map into geographical regions and split the countries and regions into 5 SDI regions based on the spectrum of development: high, high-middle, middle, low-middle, and low. In addition, they separated their included individuals into 6 age groups: 60 to 64 years, 65 to 69 years, 70 to 74 years, 75 to 79 years, 80 to 84 years, and 85 to 89 years. The investigators also assessed potential risk factors for an association with AML.
The analysis revealed that incidence, incidence rate, mortality, mortality rate, DALYs, and mortality rate of older patients in high SDI regions were significantly higher than other SDI regions. Moreover, the incidence rate in high SDI index regions showed a substantial annual increase, with an EAPC of 1.36 (95% CI, 1.24-1.48), while the mortality rate exhibited an upward trend, with an EAPC of 1.12 (95% CI, 1.04-1.19), and the DALYS rate showed a moderate rise with an EAPC of 0.94 (95% CI, 0.85-1.04).
Further, the middle SDI region demonstrated the highest increases in incidence, mortality, and DALYs compared with the other regions; incidence showed an “impressive” increase of 2.54 (95% uncertainty interval [UI], 1.94-3.33), mortality experienced a substantial rise of 2.46 (95% UI, 1.85-3.24), and DALYs showed a notable increase of 2.33 (95% UI, 1.74-3.08). The low SDI region had the lowest incidence, mortality, and DALYs.
Among the geographical regions and countries, the investigators found the following results:
They also noted that in 1990, the 65-to-69 age group had the highest incidence and deaths. In 2019, however, the 70-to-74 age group had the highest numbers. The 85-to-89 age group had the lowest numbers for incidence, death, and DALYs in 2019, but had the highest rates per 100,000 population for incidence, mortality, and DALYs. Across all age groups, men had higher rates for incidence, mortality, and DALYs than women.
The analysis further explored potential risk factors for AML-related deaths. Based on 2019 data, smoking, high body mass index, occupational exposure to benzene, and occupational exposure to formaldehyde were identified globally as major risk factors.
“These findings were crucial in the development of targeted prevention strategies,” the investigators said.
Overall, their results reveal that incidence, mortality, and DALYs rates showed a continuous upward trend over the 30-year period, largely driven by population aging. Furthermore, increases were strongly correlated with SDI region. The researchers said this finding could be attributed to better health care measures and diagnostic technologies, leading to increased diagnoses and consequently higher incidence and mortality rates.
The authors acknowledged limitations. The Global Burden of Disease database may not have comprehensively covered specific populations, such as ethnic minorities or certain occupational cohorts. In addition, data quality and comprehensiveness may have varied by country. Still, they believe the study focuses attention on an increasingly serious global health issue.
“As the global SDI continued to rise, the importance of AML in older people became increasingly pronounced, especially in high SDI regions,” the authors concluded. “We should have paid more attention.”
Reference
Chen P, Liu X, Zhao Y, Hu Y, et al. Global, national, and regional burden of acute myeloid leukemia among 60 – 89 years-old individuals: insights from a study covering the period 1990 to 2019. Front Public Health. Published online January 11, 2024. doi:10.3389/fpubh.2023.1329529
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen